• Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $40.00 at Oppenheimer

    Источник: Buzz FX / 13 янв 2025 10:46:16   America/Chicago


    Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $40.00 at Oppenheimer Written by MarketBeat January 13, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) had its price objective decreas
    Read more...
Опубликовать